139 related articles for article (PubMed ID: 3463446)
1. Suppression of tumorigenicity in somatic cell hybrids. IV. Chromosomes of normal human cells associated with suppression of tumorigenicity in hybrids with D98AH2 carcinoma cells.
Klinger HP; Kaelbling M
Cytogenet Cell Genet; 1986; 42(4):225-35. PubMed ID: 3463446
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenicity in somatic cell hybrids. III. Cosegregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid x malignant cells.
Kaelbling M; Klinger HP
Cytogenet Cell Genet; 1986; 41(2):65-70. PubMed ID: 3956263
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
Klinger HP; Shows TB
J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
[TBL] [Abstract][Full Text] [Related]
4. Levels of fos, ets2, and myb proto-oncogene RNAs correlate with segregation of chromosome 11 of normal cells and with suppression of tumorigenicity in human cell hybrids.
O'Hara BM; Klinger HP; Curran T; Zhang YD; Blair DG
Mol Cell Biol; 1987 Aug; 7(8):2941-6. PubMed ID: 3670301
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
6. Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells.
Lichy JH; Modi WS; Seuanez HN; Howley PM
Cell Growth Differ; 1992 Aug; 3(8):541-8. PubMed ID: 1390339
[TBL] [Abstract][Full Text] [Related]
7. Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrids.
Srivatsan ES; Benedict WF; Stanbridge EJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6174-9. PubMed ID: 2877730
[TBL] [Abstract][Full Text] [Related]
8. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenicity in somatic cell hybrids. I. Suppression and reexpression of tumorigenicity in diploid human X D98AH2 hybrids and independent segregation of tumorigenicity from other cell phenotypes.
Klinger HP
Cytogenet Cell Genet; 1980; 27(4):254-66. PubMed ID: 6934067
[No Abstract] [Full Text] [Related]
10. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
11. Tumorigenic suppression of a human cutaneous squamous cell carcinoma cell line in the nude mouse skin graft assay.
Conway K; Morgan D; Phillips KK; Yuspa SH; Weissman BE
Cancer Res; 1992 Dec; 52(23):6487-95. PubMed ID: 1358434
[TBL] [Abstract][Full Text] [Related]
12. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
Kugoh HM; Hashiba H; Shimizu M; Oshimura M
Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
[TBL] [Abstract][Full Text] [Related]
13. Relationship between tumorigenicity and the dosage of lymphoma- vs. normal-parent-derived chromosome 15 in somatic cell hybrids between lymphoma cells with rearranged pvt-1 gene and normal cells.
Uno M; Wirschubsky Z; Wiener F; Klein G
Int J Cancer; 1989 Aug; 44(2):353-9. PubMed ID: 2788146
[TBL] [Abstract][Full Text] [Related]
14. Loss of suppressor loci on chromosomes 11 and 14 may be required for radiation-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.
Mendonca MS; Howard K; Fasching CL; Farrington DL; Desmond LA; Stanbridge EJ; Redpath JL
Radiat Res; 1998 Mar; 149(3):246-55. PubMed ID: 9496887
[TBL] [Abstract][Full Text] [Related]
15. Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybrids.
Pratt CI; Wu SQ; Bhattacharya M; Kao C; Gilchrist KW; Reznikoff CA
Cancer Genet Cytogenet; 1992 Apr; 59(2):180-90. PubMed ID: 1316224
[TBL] [Abstract][Full Text] [Related]
16. Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II.
Misra BC; Srivatsan ES
Am J Hum Genet; 1989 Oct; 45(4):565-77. PubMed ID: 2577469
[TBL] [Abstract][Full Text] [Related]
17. DNA polymorphisms indicate loss of heterozygosity for chromosome 11 of D98AH2 cells.
Kaelbling M; Roginski RS; Klinger HP
Cytogenet Cell Genet; 1986; 41(4):240-4. PubMed ID: 3011364
[TBL] [Abstract][Full Text] [Related]
18. Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer.
Satoh H; Lamb PW; Dong JT; Everitt J; Boreiko C; Oshimura M; Barrett JC
Mol Carcinog; 1993; 7(3):157-64. PubMed ID: 8098218
[TBL] [Abstract][Full Text] [Related]
19. Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.
Mendonca MS; Fasching CL; Srivatsan ES; Stanbridge EJ; Redpath JL
Radiat Res; 1995 Jul; 143(1):34-44. PubMed ID: 7597142
[TBL] [Abstract][Full Text] [Related]
20. The role of chromosome 15 in murine leukemogenesis. I. Contrasting behavior of the tumor vs. normal parent-derived chromosomes No. 15 in somatic hybrids of varying tumorigenicity.
Spira J; Wiener F; Babonits M; Gamble J; Miller J; Klein G
Int J Cancer; 1981 Dec; 28(6):785-98. PubMed ID: 7333707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
